Ed Carr

VP, Chief Accounting Officer at Abeona Therapeutics - New York, NY, US

Ed Carr's Colleagues at Abeona Therapeutics
Scott Nogi

Vice President, Business Operations

Contact Scott Nogi

Gregory Gin

Vice President of Investor Relations

Contact Gregory Gin

Jodie Gillon

VP, Patient Advocacy & Clinical Affairs

Contact Jodie Gillon

Dan Rudin

Vice President

Contact Dan Rudin

James Bircher

Chief Technology Officer

Contact James Bircher

Adam Davis

Director of Manufacturing

Contact Adam Davis

Julie Block

Director CMC Regulatory Compliance

Contact Julie Block

View All Ed Carr's Colleagues
Ed Carr's Contact Details
Email (Verified)
***@abeonatherapeutics.com
Get Ed Carr's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Ed Carr's Mobile Number
HQ
214-665-9495
Location
Company
Abeona Therapeutics
Ed Carr's Company Details
Abeona Therapeutics logo, Abeona Therapeutics contact details

Abeona Therapeutics

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The Company's multi-platform expertise across the manufacture, delivery, development, and discovery of novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company's robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM™ Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery. A robust and diverse pipeline is led by a novel gene-corrected cell therapy poised to enter Phase 3 in mid-2019 and complemented by one-time gene therapy candidates across four lysosomal storage diseases. Several preclinical discoveries are led by an emerging program in cystic fibrosis that uses the AIM vector platform and a capsid that has shown potential across inherited and acquired retinal diseases.

Gene Therapy Human-derived plasma proteins Biotechnology Pharma Oncology supportive care Ovarian Cancer Alpha-1 deficiency IVIG Ultra orphan proteins Oral Mucositis Rare Disease Sanfiippo Syndrome Type A Sanfiippo Syndrome Type B MPS IIIA juvenile Batten Disease Fanconi anemia Infantile Batten Disease Epidermolysis Bullosa Lysosomal Storage Disease Cell Therapy Pediatric Rare Diseases manufacturing B2B Biotech SaaS Commercial Physical Research
Details about Abeona Therapeutics
Frequently Asked Questions about Ed Carr
Ed Carr currently works for Abeona Therapeutics.
Ed Carr's role at Abeona Therapeutics is VP, Chief Accounting Officer.
Ed Carr's email address is ***@abeonatherapeutics.com. To view Ed Carr's full email address, please signup to ConnectPlex.
Ed Carr works in the Biotechnology industry.
Ed Carr's colleagues at Abeona Therapeutics are Scott Nogi, Gregory Gin, Jodie Gillon, Dan Rudin, James Bircher, Adam Davis, Julie Block and others.
Ed Carr's phone number is 214-665-9495
See more information about Ed Carr